Stomach cancer and esophageal cancer are two types of digestive system cancers with similar symptoms. Although the typical risk factors for cancer can contribute to the development of stomach cancer and esophageal cancer, Zantac use may be an additional risk factor. The medication has been linked to cancer diagnoses nationwide.
Stomach Cancer Symptoms
It is important to remember that stomach cancer may initially be asymptomatic. Stomach cancer risk factors include age (older people are more likely to be diagnosed), gender (stomach cancer is primarily seen in men), family history, diet, obesity, toxic exposure, and tobacco and alcohol use.
Stomach cancer can be diagnosed through a biopsy, endoscopy, x-ray, MRI, ultrasound, and other tests. This type of cancer is not usually detected before symptoms appear. People who are at risk of developing stomach cancer should be aware of all potential signs.
The signs and symptoms of stomach cancer may include:
- Blood in the stool or dark stool
- Vomiting blood
- Indigestion
- Nausea
- Loss of appetite
- Weight loss
- Fatigue
- Difficulty swallowing
- Feeling full and bloated
Esophageal Cancer Symptoms
Like stomach cancer, esophageal cancer is rarely identified before the appearance of symptoms. If you have any signs of esophageal cancer and are a regular Zantac user, you should immediately contact your doctor. Imaging tests, barium swallow tests, endoscopies, and biopsies can be used to diagnose esophageal cancer. Esophageal cancer is also similar to stomach cancer because it is more common in older people, men, obese people, and tobacco and alcohol users.
The following symptoms may be signs of esophageal cancer:
- Abdominal pain
- Blood in the stool or dark stool
- Difficulty swallowing
- Weight loss
- Heartburn
- Vomiting blood
- Indigestion
- Chest pain
- Nausea
- Loss of appetite
- Anemia
Does Zantac Cause Cancer?
Zantac use has been associated with cancers of the digestive system, such as stomach and esophageal cancer. The medication tested positive for N-Nitrosodimethylamine (NDMA), which is a known carcinogen. This discovery and the cancer diagnosis claims of people across the United States have prompted a recall of Zantac and other ranitidine medications, along with related litigation.
The Spangenberg Shibley & Liber LLP legal team represents people who are regular Zantac users and developed cancer. Contact us to discuss the details of your case.
If you or a loved one use Zantac and have been diagnosed with cancer, complete our contact form or call (216) 600-0114 to schedule a free consultation with our attorneys.
